Lane Alderson, APRN
Women's Health · Fayetteville, ARNPI 1851024996
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $628 of the $728 with a category attached, or 86.3%. 12 manufacturers reported payments, led by Astellas Pharma US Inc at 39.0% of the total.
Across 24 payments — averaging $30.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$284
- Amgen$124
- Mayne Pharma Commercial LLC$68
- Astellas Pharma Global Development$49
- Bayer$43
- Sumitomo Pharma America, Inc.$39
- plus $122 from 6 others
What the payments were for
- Food & beverage$62886%
- Education$10014%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 6 | $284 |
| Amgen | 1 | $124 |
| Mayne Pharma Commercial LLC | 5 | $68 |
| Astellas Pharma Global Development | 2 | $49 |
| Bayer | 2 | $43 |
| Sumitomo Pharma America, Inc. | 2 | $39 |
| AbbVie | 1 | $27 |
| Organon | 1 | $26 |
| Merck | 1 | $18 |
| Shield Therapeutics Inc | 1 | $17 |
| Millicent US Inc | 1 | $17 |
| Exact Sciences | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$728 in reported general payments places this provider in the 65th percentile of 44 women's health providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 123 | $41,987 |
| EliquisApixaban | 119 | $34,910 |
| RytaryCarbidopa/Levodopa | 49 | $27,083 |
| JardianceEmpagliflozin | 37 | $11,557 |
| FarxigaDapagliflozin Propanediol | 27 | $7,846 |
| TradjentaLinagliptin | 16 | $4,225 |
| LevemirInsulin Detemir | 12 | $2,388 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 80 | $2,128 |
| Divalproex Sodium | 25 | $2,114 |
| Potassium Chloride | 99 | $1,967 |
| Buspirone Hcl | 76 | $1,562 |
| Sertraline Hcl | 152 | $1,462 |
| Levothyroxine Sodium | 105 | $1,451 |
| NovologInsulin Aspart | 11 | $1,230 |
| Kapspargo SprinkleMetoprolol Succinate | 36 | $1,178 |
Paid to pharmacies, not to this prescriber.
Other women's health in Fayetteville
- Lisa HarmonFayetteville$2K
- Michelle GreenFayetteville$105
- Sara RussellFayetteville$77
- Malory WatsonEl Dorado$28K
- Wendy BennettSherwood$4K
- Margaret HicksBenton$3K
- Brandi AlexanderJohnson$3K
- Amy WilsonLittle Rock$3K
- Becca AustinLittle Rock$2K
- Jeni WarriorLittle Rock$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.